US Patent Issued to MOEBIUS MEDICAL on Dec. 30 for "Long-acting liposomal composition for treatment of pain in articular disorders" (Israeli Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,272, issued on Dec. 30, was assigned to MOEBIUS MEDICAL LTD. (Tel Aviv, Israel).

"Long-acting liposomal composition for treatment of pain in articular disorders" was invented by Moshe Weinstein (Tel Mond, Israel) and Ron Pinkus (Raanana, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a subject having an articular disorder by administration of a long-acting liposomal composition. A preferred liposomal composition includes a phosphatidylcholine as the sole active ingredient, wherein the phosphatidylcholine is selected from the group consisting of 1,2-dimyristoyl-sn-glycero-3-phosphocholine, 1,2-dipalmitoyl-sn-glycero-3-phos...